2021-07-22 12:05:51 - 1 week ago -
Last Updated: 31 July 2021 - 05h24
South Africa's Biovac Institute has outlined the process it will undergo to begin manufacturing the Pfizer Covid19 vaccine.
Pfizer and BioNTech have announced a deal with Cape Town-based Biovac to process and distribute over 100 million vaccine doses a year for the African Union, beginning in 2022.
The vaccines are considered among
the most effective against the coronavirus - including the highly infectious Delta variant.
Biovac's CEO is Dr Morena Makhoana: "The Pfizer vaccine, the same one that is being rolled out in the country, we will now be manufacturing in Cape Town.
So the process is going to be from formulation to finish.
We will be receiving the raw ingredients from Pfizer's facility in Europe and we will be doing a downstream process which is for finish."
Login or Create your NARI Profile
Click here to Edit social accounts
TIP: You can save your Location Settings in your Dashboard.
Notice that this post / article includes video content. Watch the video in the article.